Gary M. Gray

Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue

Prolyl endopeptidases have potential for treating coeliac sprue, a disease of the intestine caused by proteolytically resistant peptides from proline-rich prolamins of wheat, barley and rye. We compared the properties of three similar bacterial prolyl endopeptidases, including the known enzymes from Flavobacterium meningosepticum (FM) and Sphingomonas capsulate (SC) and a novel enzyme from Myxococcus xanthus (MX). These enzymes were interrogated with reference chromogenic substrates, as well as two related gluten peptides (PQPQLPYPQPQLP and LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF), believed to play a key role in coeliac sprue pathogenesis. In vitro and in vivo studies were conducted to evaluate the activity, specificity and acid/protease stability of the enzymes. All peptidases were relatively resistant to acid, pancreatic proteases and membrane peptidases of the small intestinal mucosa. Although their activities against reference substrates were similar, the enzymes exhibited substantial differences with respect to chain length and subsite specificity. SC hydrolysed PQPQLPYPQPQLP well, but had negligible activity against LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF. In contrast, the FM and MX peptidases cleaved both substrates, although the FM enzyme acted more rapidly on LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF than MX. Whereas the FM enzyme showed a preference for Pro-Gln bonds, SC cleaved both Pro-Gln and Pro-Tyr bonds with comparable efficiency, and MX had a modest preference for Pro-(Tyr/Phe) sites over Pro-Gln sites. While a more comprehensive understanding of sequence and chain-length specificity may be needed to assess the relative utility of alternative prolyl endopeptidases for treating coeliac sprue, our present work has illustrated the diverse nature of this class of enzymes from the standpoint of proteolysing complex substrates such as gluten.

Effect of Pretreatment of Food Gluten With Prolyl Endopeptidase on Gluten-Induced Malabsorption in Celiac Sprue

BACKGROUND & AIMS We sought to determine whether prolyl endopeptidase (PEP) treatment of food gluten would obviate the intestinal dysfunction produced by small amounts of dietary gluten supplement in patients with celiac sprue. METHODS Twenty asymptomatic patients with histologically proven celiac sprue completed a randomized, double-blind, cross-over study involving two 14-day stages. Each patient consumed a low dose of a gluten supplement daily (5 g; equivalent to 1 slice of bread) in 1 stage and gluten pretreated with PEP in the other stage. Patients completed a daily symptom questionnaire and a D-xylose urine excretion and a 72-hour quantitative fecal fat were monitored before and after each stage. RESULTS Despite clinical remission at baseline, 40% of patients had at least 1 abnormal celiac antibody, 20% had an abnormal urine xylose, and 63% had an abnormal fecal fat test result. There was no difference in symptoms as a function of the type of gluten consumed. In response to gluten not treated with PEP, an appreciable proportion of patients developed malabsorption of fat (7 of 17, 41%) or xylose (8 of 14, 57%). When the gluten was pretreated with PEP, fat malabsorption was avoided in 5 of 7 and xylose malabsorption in 4 of 8 of these same patients. CONCLUSIONS A significant proportion of asymptomatic patients with celiac sprue have abnormal celiac antibodies and fat or carbohydrate malabsorption. Pretreatment of gluten with PEP avoided the development of fat or carbohydrate malabsorption in the majority of those patients who developed fat or carbohydrate malabsorption after a 2-week gluten challenge.

Retinal Hemorrhage at High Altitude

IN July, 1968, retinal disorders were found to have developed in two persons working at 17,500 feet on Mount Logan, Yukon Territory: one of them had papilledema and was semicomatose. In July, 1969,...

Intestinal β-galactosidases: I. Separation and characterization of three enzymes in normal human intestine

Previous studies based on work in the rat and preliminary experiments with human intestine have suggested that two beta-galactosidases are present in small intestine, and it is believed that only one of these enzymes is a lactase important for the digestion of dietary lactose. The high prevalence of intestinal lactase deficiency in man prompted more complete study of these enzymes. Human intestinal beta-galactosidases were studied by gel filtration on Sephadex G-200 and Biogel P-300 as well as by density gradient ultracentrifugation. Gel filtration produced partial separation into three peaks of enzyme activity, but much activity against synthetic substrates was lost. Only the trailing peak with specificity for synthetic beta-galactosides was completely separated from the other enzymes. Thus gel filtration was not a suitable preparative procedure for biochemical characterization. Density gradients separated the enzymes more completely, and they were designated according to their sedimentation rates and further characterized. Enzyme I has a molecular weight of 280,000, pH optimum of 6.0, and specificity for lactose of at least five times that for cellobiose or synthetic substrates. A second lactase, enzyme II, possesses slightly greater activity against lactose than for some synthetic substrates and is incapable of splitting cellobiose. Further, it has a lower pH optimum (4.5) and is present in two molecular species (molecular weights 156,000 and 660,000). Enzyme III shows specificity only for synthetic beta-galactosides but has a pH activity curve identical with enzyme I and a molecular weight of 80,000. Whereas human liver and kidney contain a beta-galactosidase with the same biochemical characteristics as intestinal enzyme II, enzymes I and III appear to be peculiar to intestine, and enzyme I most probably represents the lactase of importance in the mucosal digestion of dietary lactose. The following paper considers this further in terms of the biochemical change in intestinal lactase deficiency.

Intestinal surface peptide hydrolases: identification and characterization of three enzymes from rat brush border.

Peptide hydrolases were solubilized from rat small intestinal brush border by papain and separated by Sephadex G-200 chromatography, velocity gradient ultracentrifugation and polyacrylamide disc electrophoresis and designated according to approximate molecular size from sedimentation studies. Peptidases I (apparent Mr 230 000) and II (apparent Mr 160 000) are oligopeptidases with maximum specificity for tripeptides with identical pH optima (7.5) and similar apparent Km with L-Leu-Gly (I, 0.60 MM; II, 0.76 mM). L-Leucyl-beta-naphthylamide is a competitive inhibitor of both enzymes. Concentration of peptidase II produced partial conversion to peptidase I on polyacrylamide disc electrophoresis. The third peptide hydrolase (III, Mr 120 000) is a dipeptidase with pH optimum 8.5 and apparent Km for L-Leu-Gly of 0.65 mM. These peptide hydrolases were inhibited appreciably (37-59%) by 0.2 M glycine/NaOH, Tris - HCl or Tris - glycine buffers. EDTA (5 mM) completely inhibited these enzymes but all activity was restored by dialysis against buffer without divalent ions. Subsequent addition of Mg2+, Mn2+, Co2+ or Zn2+ (1-2 mM) inhibited peptidases I and II variably (4-81%) depending upon the substrate and buffer used. In contrast peptidase III was activated slightly by metal ions (5-20%). These peptide hydrolases are strategically located at the intestinal lumen-cell interface and possess biochemical characteristics making them ideally suited to play a pivotal role in the final stage of protein digestion.

Location and Activity of Ulcerative and Crohn's Colitis by Indium 111 Leukocyte Scan: A Prospective Comparison Study

A prospective blinded study comparing the indium 111 leukocyte scan to barium enema, colonoscopy, or surgery or a combination of these, was carried out in 15 patients (10 with active ulcerative colitis and 5 with active Crohns colitis). Correlation of disease location to colonic regions between indium scan and other diagnostic studies was excellent in 11 instances, good in 2, and poor in 3. In 2 of the 3 studies where major disagreement occurred, the comparative barium enema was performed greater than 2 mo after the indium scan. Disease activity, estimated by the intensity of radionuclide uptake, was compared to clinical disease activity assessed by the Crohns Disease Activity Index for both forms of colitis. The relative degree of inflammation estimated by the indium scan correlated well with the independent clinical assessment (correlation coefficient = 0.81). The indium 111 leukocyte scan appears to be an accurate, noninvasive method for assessing the extent and the severity of the inflammation in patients with acute ulcerative or Crohns colitis.

Intestinal Assimilation of a Tetrapeptide in the Rat: OBLIGATE FUNCTION OF BRUSH BORDER AMINOPEPTIDASE

The small intestine is capable of taking up peptide nutrients of two or three amino acid residues, but the mechanism of intestinal assimilation of larger oligopeptides has not been established. The amino-oligopeptidase of the intestinal brush border possesses high specificity for oligopeptides having bulky side chains and is a candidate for a crucial role in the overall assimilation of dietary protein. Rat jejunum was used for in vitro gut sac and in vivo perfusion experiments with Gly-l-Leu-Gly-Gly (2 mM) as the test substrate with analysis of parent peptide and products by automatic ion-exchange chromatography. In these experiments, the tetrapeptide disappeared rapidly from the test solution (20 mumol/s per cm(2) in vitro; 17 mumol/s per cm(2) in vivo) by sequential removal of amino acid residues from the N-terminus to yield amino acids and the C-terminal dipeptide. In gut sac experiments, 61-100% of these products of hydrolysis appeared in the incubation medium and the remainder in the tissue. In contrast, only small amounts of hydrolytic products were found within intestinal lumen in vivo.Gly-l-Pro (10 mM), a peptide known to be transported intact but not to be hydrolyzed by the brush border aminopeptidase, failed to inhibit Gly-l-Leu-Gly-Gly disappearance suggesting that the tetrapeptide does not utilize the known intact transport mechanism. Hypoxic conditions (N(2) atmosphere) in vitro markedly inhibited transport of glucose, leucine, and Gly-Gly but failed to impair Gly-l-Leu-Gly-Gly disappearance suggesting that the first step in assimilation of the tetrapeptide does not involve a transport process. Disappearance of the tetrapeptide was completely blocked by l-leucyl-beta-naphthylamide (10 mM), a specific substrate for brush border aminopeptidase and by the phthalimido derivative of l-leucine bromomethyl ketone, a potent peptidase inhibitor. Hence, the amino-oligopeptidase at the intestinal surface appears to be essential for the initial stages of assimilation of this model tetrapeptide.

Sucrase-isomaltase deficiency. Absence of an inactive enzyme variant.

Deficiency of sucrase-isomaltase, an intestinal enzyme complex that is essential for digestion of nutritionally important carbohydrates, appears to be inherited as an autosomal recessive in 0.2 per cent of North Americans. The molecular basis of the deficiency has not been elucidated. To characterize the enzyme defect quantitatively, papain-solubilized intestinal biopsies were analyzed for total enzyme protein by radioimmunoassay and for enzyme activity by hydrolytic assay. Normal intestine had a close correlation between immunologically reactive enzyme and enzymic activity. In contrast, seven patients with sucrase-isomaltase deficiency were found to have complete absence of the enzyme protein by radioimmunoassay even though up to 10 times more intestinal protein was present than with normal tissue. This absence of an inactive enzyme variant can be explained by a major (no-sense) mutation of the structural gene or by a complete repression of the regulatory mechanism that controls structural gene function.

Intestinal β-galactosidases: II. Biochemical alteration in human lactase deficiency

Despite the high prevalence of intestinal lactase deficiency in some racial groups and in patients with intestinal disease, the biochemical defect has not been characterized. In the preceding paper normal intestine was found to have two lactases with distinctly different pH optima. Therefore, pH activity curves of homogenates from lactase-deficient intestine were studied, and the pH optimum was found to be shifted from the normal of 5.8 to 4.8. Density gradient ultracentrifugation of intestinal material from five lactase-deficient patients demonstrated absence of a lactase with pH optimum 6.0 and molecular weight 280,000. A second lactase with pH optimum 4.5 and molecular weights of 156,000 and 660,000 remained at normal levels accounting for the shift in the pH optimum in whole intestinal homogenates. In addition, three of the five patients had absence of a smaller beta-galactosidase (molecular weight 80,000) that had specificity only for synthetic substrates. Although not a lactase, this enzyme had a pH optimum identical with the missing lactase, and its activity was inhibited by lactose in a partially competitive manner suggesting that it is capable of binding lactose. It is possible that this enzyme is a precursor or fragment of the missing lactase.The residual lactase activity provided by the lactase with low pH optimum represents 20-70% of the activity of the missing enzyme, and yet these patients are not able to digest dietary lactose. Thus it appears that the residual enzyme plays no significant role in the hydrolysis of ingested lactose.

Persistent Deficiency of Intestinal Lactase in Apparently Cured Tropical Sprue

Summary Thirty-seven Puerto Rican patients with untreated tropical sprue all had deficiency of intestinal lactase and two-thirds of them also were deficient for sucrase and maltase. A separate group of 48 patients who had been treated for 3 months to 4 years with folic acid or antibacterial agents were found to have no malabsorption, megaloblastic anemia, or intestinal histological abnormalities and their sucrase and maltase activities were normal. However, 63% still had lactase deficiency, a prevalence 3 times that of a control group. Nineteen patients were studied at the time of diagnosis and serially while receiving therapy. After treatment for 3 to 18 months (mean, 11 months) lactase deficiency continued in 75% of patients as the sole residual manifestation of tropical sprue. Thus it appears that this single enzyme deficiency can be caused by prior intestinal disease or current subclinical illness, and findings of such a deficiency in the absence of other clinical illness may warrant evaluation for an underlying intestinal disease.